Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control

Beta blocker use in subjects with type 2 diabetes mellitus and systolic heart failure does not worsen glycaemic control

<p>Abstract</p> <p>Background</p> <p>The prognostic benefits of beta-blockers (BB) in patients with systolic heart failure (SHF) are known but despite this, in patients with diabetes they are underutilized. The aim of this study was to assess the effect of beta-blockers...

Full description

Bibliographic Details
Main Authors: Wai Bryan, Kearney Leighton G, Hare David L, Ord Michelle, Burrell Louise M, Srivastava Piyush M
Format: Article
Language:English
Published: BMC 2012-02-01
Series:Cardiovascular Diabetology
Subjects:
Beta-blockers
Diabetes
Systolic heart failure
Glycaemic control
Online Access:http://www.cardiab.com/content/11/1/14

Internet

http://www.cardiab.com/content/11/1/14

Similar Items